Avoid Chinese vaccines until more information is available - Expert Committee
The Committee of Experts appointed to study Covid vaccines has informed the National Medicines Regulatory Authority (NMRA) that the information provided by the Chinese vaccine manufacturer was insufficient to determine the immunization, safety and efficacy of the vaccine developed in China against the Covid virus and that, therefore, the vaccine should not be used until further information is available.